Category: Professional Posters
Purpose: The use of “triggers,” or “clues,” to identify adverse drug events (ADEs) is an effective method for measuring the overall level of harm from medications in a health care setting (IHI-2019). Inadequate risk perception about newly marketed drugs may lead to undermine certain ADRs or simply render us unable to detect them when they happen.
Aim of the study:
• To investigate if the use of trigger drugs tool could improve the identification of ADRs in Alkhor hospital
• To quantify the degree and severity of harm.
Methods: A Prospective study conducted in Al khor hospital between Feb 2018 to Dec 2018 where adult inpatient (>14 years) open files were monitored using “trigger drugs tool” method, in addition, “abrupt stop of medication” method was used in the outpatient area.
Before starting the project, an educational awareness lecture was conducted at AKH hospital (physicians, pharmacists and nurses)
The trigger tool was distributed to all departments of Alkhor hospital to spread awareness and ease access to the tool.
All suspicious ADRs were confirmed by clinical experts using the HMC definition of ADRs, and then reported according to the process map.
Results: The data showed an increase in ADRs reporting between 2017-2018 from 40 reports to 137 reports, 58% of the ADRs detected by the trigger drugs tool, while 42% by the traditional method. The data also showed that clinical pharmacists are the higher reporter 59%, followed by the nurses 22%, pharmacists 18% and physicians 1%.clinical pharmacists reporting increased from 18 ADRs in 2017 to 93 in 2018. Majority of ADR’s reported in 2018 were caused by antibiotics (21%), followed by antihypertensive (10.6%). Analgesics, anticoagulants, anti-hyperglycemic and control medications caused nearly the same percentage of reported ADR’s (6%). Reported ADR’s were classified based on the harm level caused for the patient. 32% of patients were reported to have no harm from the reported ADR’s while 34% caused no harm but the patient needed monitoring. On the other hand 24% of ADR’s caused temporary patient harm that needed treatment with an antidote or other medication used in the intervention. However only 10% of the cases needed hospitalization.
Conclusion: ADRs are under reported in Al Khor Hospital.
“Trigger drugs tool” method increased ADRs reports to more than 100% via an easy review process. Clinical pharmacists play an important role in identification and management of ADRs in Al Khor Hospital.
Education of the importance of ADRs is crucial and important to further stimulate healthcare providers to document ADRs and not just manage them with no documentation.